Mustafa Bilici

Mustafa Bilici

Auto-generated profile, based on publicly available information

Mustafa Bilici

Department of Psychology, Istanbul Gelisim University, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2001 in Journal of Affective Disorders
Verified
Journal Article
Closed access
MBMustafa Bilici
Mustafa Bilici
HEHasan Efe
Hasan Efe
MKM.ARif Köroğlu
M.ARif Köroğlu
HUHüseyin Avni Uydu
Hüseyin Avni Uydu
MBM. Bekaroğlu
M. Bekaroğlu
ODO. Değer
O. Değer

1 January 2004 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
MBMustafa Bilici
Mustafa Bilici
FYFatma Yıldırım
Fatma Yıldırım
SKSema Kandil
Sema Kandil
MBMehmet Bekaroğlu
Mehmet Bekaroğlu
SYSermet Yıldırmış
Sermet Yıldırmış
HAHatice Aksu
Hatice Aksu


1 June 2004 in SLEEP
Verified
Journal Article
Open access
PDF file
MAMehmet Y Agargun
Mehmet Y Agargun
ACAli Savas Cilli
Ali Savas Cilli
SSSahnur Sener
Sahnur Sener
MBMustafa Bilici
Mustafa Bilici
OOOmer Akil Ozer
Omer Akil Ozer
EKElvan Karacan
Elvan Karacan
To survey the prevalence of parasomnias in a population of children aged 7 to 11 years and to determine whether parasomnias are associated with medical and neurobehavioral properties. Parents and children completed a pediatric sleep questionnaire that contains 27 items developed by the authors to assess parasomnias in children. Parents and children were also interviewed about the children's medical and sociofamilial history, schooling, psychological difficulties, medication intake, and the history of psychomotor and psychosocial development. NA 971 preadolescent school-aged children from 4 locations in Turkey participated in the study. We found a 14.4% prevalence of parasomnia in preadolescent school-aged children. Almost every sixth child had about at least 1 parasomnia. When we examined parasomnias separately, bruxism, nocturnal enuresis, and night terrors were the most common parasomnias among both girls and boys. The prevalence of parasomnias was higher in the 9-and 10-year-old age groups than in the other age groups. Girls and boys did not differ. Children with parasomnias had higher rates of past physical illness, delays in toilet raining, behavior disturbances, adjustment problems, and learning difficulties. These results suggest that the prevalence of parasomnias was high in the 9- and 10-year-old age groups. Parasomnias are associated with a history of physical illness and neurobehavioral abnormalities.

1 November 2003 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
YAYıldız Akvardar
Yıldız Akvardar
YDyucel demiral
yucel demiral
GEGül Ergör
Gül Ergör
AEAlp Ergör
Alp Ergör
MBMustafa Bilici
Mustafa Bilici
ÖÖÖmer Akil Özer
Ömer Akil Özer

1 January 2002 in International Journal of Neuroscience
Verified
Journal Article
Closed access
MBMustafa Bilici
Mustafa Bilici
HCHasim Cakirbay
Hasim Cakirbay
MGMustafa Guler
Mustafa Guler
MTMehmet Tosun
Mehmet Tosun
MUMetin Ulgen
Metin Ulgen
UTUner Tan
Uner Tan
There are some reports that classical neuroleptics may lead to osteoporosis or reduced bone mineral density (BMD). However, there is no adequate information about the effects of atypical neuroleptics on BMD. The aim of this study was to measure BMD in schizophrenic patients taking class -ical and atypical neuroleptics, compared to healthy controls. Seventy- five patients with schizophrenia (40 taking classical neuroleptics [CN], 35 taking atypical neuroleptics [AN]) and 20 healthy controls (HC) were included in the study. Spine (L1 L4) BMD was measured by dual-energy X-ray absorptiometry. ANOVA showed that BMD was higher in HC than AN and CN. In addition, there was a negative correlation between the duration of neuroleptic treatment and BMD and the duration of the illness. These findings suggest that atypical neuroleptics may be safer than the classical neuroleptics in terms of reduced BMD.